Differential effects of enzyme induction on antipyrine metabolite formation. - Wikidata - awgldk - TriplyDB

Differential effects of enzyme induction on antipyrine metabolite formation.

Differential effects of enzyme induction on antipyrine metabolite formation.

http://www.wikidata.org/entity/Q42021525

about

A comparative study of the relative enzyme inducing properties of anticonvulsant drugs in epileptic patients Predicting toxicokinetic parameters in humans from toxicokinetic data acquired from three small mammalian species.Solid phase extraction and simultaneous high performance liquid chromatographic determination of antipyrine and its major metabolites in urine.The disposition of antipyrine and its metabolites in young and elderly healthy volunteers.Disposition of antipyrine in African patients with Hodgkin's lymphoma Antipyrine clearance and metabolite formation in children with congenital adrenal hyperplasia.Antipyrine clearance and metabolism in patients with psoriasis.Assessment of the drug metabolism capacity of the liver.Antipyrine metabolism in relation to polymorphic oxidations of sparteine and debrisoquine.Effect of chloroquine and primaquine on antipyrine metabolism Influence of rifampicin treatment on antipyrine clearance and metabolite formation in patients with tuberculosis Accuracy and clinical utility of simplified tests of antipyrine metabolism Induction and autoinduction properties of rifamycin derivatives: a review of animal and human studies.Metronidazole and antipyrine as probes for the study of foreign compound metabolism.Assessment of enzyme induction and enzyme inhibition in humans: toxicological implications.Two- and four-day rifampin chemoprophylaxis regimens induce oxidative metabolism.Human cytochromes P-450.Noninvasive assessment in vivo of hepatic drug metabolism in health and disease.Tolbutamide as a model drug for the study of enzyme induction and enzyme inhibition in the rat.Antipyrine clearance and metabolite formation: the influence of liver volume and smoking.Metabolism of the aldose reductase inhibitor ALO1567 in man.Antipyrine clearance and metabolite formation in patients with alcoholic cirrhosis.Effect of pregnenolone carbonitrile, promethazine and antipyrine pretreatment on antipyrine metabolite formation in rats.The influence of Org 10172, a low molecular weight heparinoid, on antipyrine metabolism and the effect of enzyme induction on the response to Org 10172 Antipyrine metabolite kinetics in rats: studies on dose and time dependence.Biliary excretion of antipyrine and its metabolites after cholecystectomy.Antipyrine metabolite kinetics in healthy human volunteers during multiple dosing of phenytoin and carbamazepine.Metabolism of antipyrine and sulphadimidine in dwarf goats: effects of the enzyme-inducing agents phenobarbital, troleandomycin and rifampicin.Effects of salbutamol on the absorption and disposition of sulphamethoxazole in adult volunteers.

P2860

Q24544077-EFEFF3CC-14CB-4287-8C27-4D5C2EC33F9C Q30941085-36689C86-2D49-40E7-8AC7-AB501084939D Q30963437-EA714407-BB64-4307-8D04-A091AD938DEE Q34416893-BE525B7A-B3E0-4FB3-AD9E-BB7B67CB94CE Q34417385-374A796B-90AE-4CB5-BE02-964266B98C20 Q34447041-5033DA69-1FB8-4357-A5D2-E88E432BCA65 Q34448073-6865442F-D273-4E9E-8DCE-209A750BE20C Q34511238-D6BDBC40-F05F-4AAE-9A80-F354D5D59E47 Q34512351-FE2063E8-AD4D-48F0-940A-1DF9FE7DEEEF Q34513366-CD35A377-8837-4416-8E5C-E0DF8E580036 Q34621602-E90504E9-41F9-40C2-97D7-A2A2EAAF38EE Q34621803-46333585-FEC4-4B42-8454-D4D8A87D6EA8 Q35030873-1401A64C-AC37-4037-8F9C-77984FA40305 Q37918077-6AA1504E-9BF9-47AF-AC57-853E51A91372 Q38023213-05ABD7FE-EAB0-493E-B04A-05C4DE6A5D49 Q39879718-25DDD15F-5107-4DCD-BE91-F844AA2764B9 Q40176472-4CB9E6DE-A3CD-45EC-BE62-36994FD7E854 Q40181732-61B135FE-F280-4C1B-92E5-B2D4878CDAB3 Q41747906-DB5CD390-07FC-46C5-952D-D1972437CBCC Q41861668-0A402B03-9211-4433-BE1A-F51B2B278DAE Q41876962-50421EDF-9C0B-4E18-AB33-1882894FC467 Q42040905-A9463E8C-B8BA-457C-9A47-473DD2A5AB68 Q42223320-F1C2416D-750E-4077-ACF9-5E6CCB809EDA Q42242347-210D78A0-0467-417F-AF9B-DB1A9A2DC45C Q42248544-261626DB-FE68-4980-B109-063DA1E81C63 Q43229208-68FD7D12-8C13-481F-AAB3-BDA42F0117AA Q43240294-EF20A325-4A5D-4D2D-84FB-2F19343D49FB Q46801997-0E4E96E7-A07F-4CF4-BC5B-60D13C3877B0 Q50690993-8728ED24-5A9A-4C66-956E-A468F1A4B10F

P2860

Differential effects of enzyme induction on antipyrine metabolite formation.

http://www.wikidata.org/entity/Q42021525

description

1982 nî lūn-bûn

@nan

1982年の論文

@ja

1982年論文

@yue

1982年論文

@zh-hant

1982年論文

@zh-hk

1982年論文

@zh-mo

1982年論文

@zh-tw

1982年论文

@wuu

1982年论文

@zh

1982年论文

@zh-cn

name

Differential effects of enzyme induction on antipyrine metabolite formation.

@en

Differential effects of enzyme induction on antipyrine metabolite formation.

@nl

type

label

Differential effects of enzyme induction on antipyrine metabolite formation.

@en

Differential effects of enzyme induction on antipyrine metabolite formation.

@nl

prefLabel

Differential effects of enzyme induction on antipyrine metabolite formation.

@en

Differential effects of enzyme induction on antipyrine metabolite formation.

@nl

P1433

Q42021525-9657865F-5C4A-41CE-8C6D-6A95F028F503

P1476

Q42021525-4EBBF84D-ECA5-474E-B6D6-71F4818B3CAD

P2093

Q42021525-101D6016-FC33-4871-A461-E0D668EC809E

Q42021525-1857F7A5-13AF-4D7B-8AC1-18E3D6C6417C

Q42021525-2AEA2197-6BD2-48C9-8334-C323CB5ED997

Q42021525-39181560-8A3C-44AE-8027-E29588DEEE26

Q42021525-E55C07B1-C607-460F-A9DD-D6E85CD753D2

P2860

Q42021525-007E34CE-A691-4239-BE3C-337574CBD759

Q42021525-082312B3-59BB-4FD2-B55F-B2B31DDB75C6

Q42021525-0A95B3D2-634C-4573-B12C-B73339090831

Q42021525-256D4D14-FFE0-4F98-8134-BF2D49E40279

Q42021525-25B21EFD-4F13-467C-946A-9252BD4F3028

Q42021525-39D72457-DF3F-4F9B-9E4D-1B676DCDE2E8

Q42021525-40E62E9D-5FA2-4455-BB18-568334BA880C

Q42021525-4D4B55A7-DBCB-4560-9ACD-795D06BD9BEB

Q42021525-604E3FD2-D184-4A3C-8C54-8C22BD62A57B

Q42021525-62555981-6F94-431D-8FB1-AC2ABC44EDB3

P304

Q42021525-46D2B45D-9660-46B4-BFBB-7501D8C5C565

P31

Q42021525-71F362C0-BBE9-4718-A2B5-A64B84FBA2CA

P356

Q42021525-6ABFB49B-E761-4836-8A6F-9633F7A4BB62

P407

Q42021525-63E0C0B6-B88A-4DAB-9364-A12FFF4FCBCA

P433

Q42021525-735FB225-B1C1-4CF3-AB15-C2CA0A205076

P478

Q42021525-3E90C9F1-87BB-411F-A356-7946E1241FCE

P577

Q42021525-7B2EBFEB-3B6D-4B98-B36D-DF1BFF980977

P5875

Q42021525-EA3C3759-F923-42B6-90EE-DE9EAA1C2967

P698

Q42021525-8116D9E0-C8A6-4B83-8433-3CBE7F79D900

P932

Q42021525-B38F736D-142C-465A-A61F-95F33640D359

P356

J.1365-2125.1982.TB01389.X

P1433

British Journal of Clinical Pharmacology

P1476

Differential effects of enzyme induction on antipyrine metabolite formation.

@en

P2093

Boeijinga JK

http://www.w3.org/2001/XMLSchema#string

Breimer DD

http://www.w3.org/2001/XMLSchema#string

Danhof M

http://www.w3.org/2001/XMLSchema#string

Verbeek RM

http://www.w3.org/2001/XMLSchema#string

van Boxtel CJ

http://www.w3.org/2001/XMLSchema#string

P2860

Assay of 3-carboxy-antipyrine in urine by capillary gas chromatography with nitrogen selective detection. Some preliminary results in man

On the metabolism of antipyrine (phenazone) in man (author's transl)

The relationship between liver volume, antipyrine clearance and indocyanine green clearance before and after phenobarbitone administration in man.

Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man.

Effect of enzyme induction on plasma lipids using antipyrine, phenobarbital, and rifampicin.

Measurement of urinary 6-beta-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicin.

Anomalous results of studies on drug interaction in man. II. Halofenate (mk-185) and antipyrine, bishydroxycoumarin, and warfarin.

Prophylaxis of neonatal jaundice with maternal antipyrine treatment.

Studies on the different metabolic pathways of antipyrine in rats: influence of phenobarbital and 3-methylcholanthrene treatment.

Role of tobacco smoking in pharmacokinetics.

P304

379-386

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2125.1982.TB01389.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

1982-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

16140483

http://www.w3.org/2001/XMLSchema#string

P698

7059438

http://www.w3.org/2001/XMLSchema#string

P932

1402128

http://www.w3.org/2001/XMLSchema#string